CONSPECTUS:The 2-D layers of the inorganic ion exchangerα-zirconium phosphate(Zr(HPO_(4))2·H_(2)O,α-ZrP)make this compound particularly stable to low pH,high temperature,and ionizing radiation.Initially studied...CONSPECTUS:The 2-D layers of the inorganic ion exchangerα-zirconium phosphate(Zr(HPO_(4))2·H_(2)O,α-ZrP)make this compound particularly stable to low pH,high temperature,and ionizing radiation.Initially studied for its ion exchange properties,once the conditions for its synthesis in crystalline form was accomplished by James Stynes and Abraham Clearfield in 1964,numerous other types of studies and applications followed.Extensive studies in the 1960s and 1970s on the thermodynamics of ion exchange led to insights into the intercalation mechanism of this material.The Clearfield group solved the crystal structure in 1968 and refined it in 1977.Powder methods were pioneered by the Clearfield group to solve the structure of this type of materials.In 1968 Giulio Alberti reported means to prepare zirconium phosphonates expanding the chemistry of these layered compounds.New phases of ZrP were also discovered(e.g.,γ,θ,λ,τ)and the applications ranged from heterogeneous catalysis to intercalation chemistry and solid-state proton conductors.Methods to exfoliate the layers of ZrP were developed in the 1990s as interest grew in new applications of these types of materials.For example,protein and enzyme intercalation was accomplished starting in the 1990s by the McLendon,Mallouk,and Kumar groups.In the early 2000s,the Colon group pioneered the use of théθphase of ZrP for the direct intercalation of large inorganic metal complexes that could not be directly intercalated into theαphase.Initial studies in the Colon group ranged from applications of these directly intercalated ZrP derivatives in photophysics and photochemistry,́amperometric biosensors,vapochromism,and vapoluminescence.Over the past decade,new applications of these materials have been developed in anticancer drug delivery and electrocatalysis of the oxygen evolution reaction(OER).ZrP has now proven to be a promising drug nanocarrier and its unique chemical microenvironment provided by theα-type layers and the interlayer space enhances catalytic activity for numerous types of reactions.Further elucidation of the catalytic active species under operando conditions as well as the chemical structure of drug-intercalated derivatives should provide new insights that will advance the design and development of new compounds with desired properties.The initial pioneering efforts of Clearfield and Alberti are being continued by numerous research groups providing new exciting areas of development on the chemistry of layered M(IV)phosphate and phosphonate compounds.In this Account we present the efforts of the Colon group during the past decade on studies of théapplications of ZrP for anticancer drug delivery and electrocatalysis of the OER.展开更多
基金supported by the National Science Foundation under the NSF-PREM Center for Interfacial Electrochemistry of Energy Materials(CIE^(2)M)grant DMR-1827622the NSF Center for Chemical Innovation in Solar Fuels CHE-1305124+2 种基金the Department of Energy SUNCAT Center for Interface Science and Catalysis DE-AC02-76SF00515.We acknowledge the Texas A&M University(TAMU)Microscopy and Imaging Center for the TEM facilities and the TAMU X-ray powder diffraction facilities.Río Piedras single crystal X-ray diffrac-tometer at The University of Puerto Rico was acquired through the support of the NSF under the major instrumentation award CHE-1626103.M.V.R.-G.was supported by the NSF-PREM CIE2 M grant,DMR-1827622.J.G.-V.acknowledges the Bridge to the Doctorate Fellowship from the Puerto Rico Louis Stokes Alliance for Minority Participation(PR-LSAMP)grant HRD-1826558the UPR NASA Space Grant Program grant NNX15AI11H,and the Chateaubriand Fellowship of the France Embassy in Washington,D.C.A.L.-C.acknowledges the PEAF program of the University of Puerto Rico,Río Piedras.The authors acknowledge that part of this work was performed at the Stanford Nano Shared Facilities(SNSF)supported by the National Science Foundation under award ECCS-1542152.
文摘CONSPECTUS:The 2-D layers of the inorganic ion exchangerα-zirconium phosphate(Zr(HPO_(4))2·H_(2)O,α-ZrP)make this compound particularly stable to low pH,high temperature,and ionizing radiation.Initially studied for its ion exchange properties,once the conditions for its synthesis in crystalline form was accomplished by James Stynes and Abraham Clearfield in 1964,numerous other types of studies and applications followed.Extensive studies in the 1960s and 1970s on the thermodynamics of ion exchange led to insights into the intercalation mechanism of this material.The Clearfield group solved the crystal structure in 1968 and refined it in 1977.Powder methods were pioneered by the Clearfield group to solve the structure of this type of materials.In 1968 Giulio Alberti reported means to prepare zirconium phosphonates expanding the chemistry of these layered compounds.New phases of ZrP were also discovered(e.g.,γ,θ,λ,τ)and the applications ranged from heterogeneous catalysis to intercalation chemistry and solid-state proton conductors.Methods to exfoliate the layers of ZrP were developed in the 1990s as interest grew in new applications of these types of materials.For example,protein and enzyme intercalation was accomplished starting in the 1990s by the McLendon,Mallouk,and Kumar groups.In the early 2000s,the Colon group pioneered the use of théθphase of ZrP for the direct intercalation of large inorganic metal complexes that could not be directly intercalated into theαphase.Initial studies in the Colon group ranged from applications of these directly intercalated ZrP derivatives in photophysics and photochemistry,́amperometric biosensors,vapochromism,and vapoluminescence.Over the past decade,new applications of these materials have been developed in anticancer drug delivery and electrocatalysis of the oxygen evolution reaction(OER).ZrP has now proven to be a promising drug nanocarrier and its unique chemical microenvironment provided by theα-type layers and the interlayer space enhances catalytic activity for numerous types of reactions.Further elucidation of the catalytic active species under operando conditions as well as the chemical structure of drug-intercalated derivatives should provide new insights that will advance the design and development of new compounds with desired properties.The initial pioneering efforts of Clearfield and Alberti are being continued by numerous research groups providing new exciting areas of development on the chemistry of layered M(IV)phosphate and phosphonate compounds.In this Account we present the efforts of the Colon group during the past decade on studies of théapplications of ZrP for anticancer drug delivery and electrocatalysis of the OER.